Evaluation of germline whole exome sequencing of early breast cancer patients with triple negative breast cancer (TNBC) included in a prospective study of neoadjuvant chemotherapy (NAC) with epirubicin and cyclophosphamide (EC) and carboplatin-paclitaxel (PC) (BSMO 2014-01)

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >Evaluation of germline whole exome sequencing of early breast cancer patients with triple negative breast cancer (TNBC) included in a prospective study of neoadjuvant chemotherapy (NAC) with epirubicin and cyclophosphamide (EC) and carboplatin-paclitaxel (PC) (BSMO 2014-01)

【24h】

Evaluation of germline whole exome sequencing of early breast cancer patients with triple negative breast cancer (TNBC) included in a prospective study of neoadjuvant chemotherapy (NAC) with epirubicin and cyclophosphamide (EC) and carboplatin-paclitaxel (PC) (BSMO 2014-01)

机译：针对三重阴性乳腺癌（TNBC）的早期乳腺癌患者的种系全外壳测序评估（TNBC）中包含联新蛋白和环磷酰胺（EC）和Carboplatin-PACLitaxel（PC）的前瞻性研究（BSSMO 2014-01）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
专利

1. Evaluation of germline whole exome sequencing of early breast cancer patients with triple negative breast cancer (TNBC) included in a prospective study of neoadjuvant chemotherapy (NAC) with epirubicin and cyclophosphamide (EC) and carboplatin-paclitaxel (PC) (BSMO 2014-01) [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：针对三重阴性乳腺癌（TNBC）的早期乳腺癌患者的种系全外壳测序评估（TNBC）中包含联新蛋白和环磷酰胺（EC）和Carboplatin-PACLitaxel（PC）的前瞻性研究（BSSMO 2014-01）
2. Weekly carboplatin plus neoadjuvant anthracycline-taxane-based regimen in early triple-negative breast cancer: a prospective phase II trial by the Breast Cancer Task Force of the Belgian Society of Medical Oncology (BSMO) [J] . Fontaine Christel, Renard Vincent, Van den Bulk Heidi, Breast cancer research and treatment. . 2019,第3期

机译：每周卡铂加上新辅助蒽霉素 - 以早期三重阴性乳腺癌的基于紫杉烷的方案：通过比利时医学肿瘤学会乳腺癌任务队的前瞻性二期试验（BSMO）
3. NEOTALA: an open-label, single-arm, multi-center, phase 2 study of talazoparib for neoadjuvant treatment of germline BRCA1/2 mutation patients with early-stage triple negative breast cancer (TNBC) [J] . Litton J., Symmans F., Gogineni K., The Breast : . 2019,第期

机译：Neotala：开放标签，单臂，多中心，第2期关于塔罗扎里布的Neoadjuvant治疗针对种系BRCA1 / 2突变患者的早期三重阴性乳腺癌（TNBC）
4. Usefulness of Adjunction of Digital Breast Tomosynthesis (DBT) to Full-Field Digital Mammography (FFDM) in Evaluation of Pathological Response after Neoadjuvant Chemotherapy (NAC) for Breast Cancer [C] . Nachiko Uchiyama, Takayuki Kinoshita, Takashi Hojo, Breast imaging . 2012

机译：全数字化乳腺X线摄影术（FFDM）与数字乳腺断层合成（DBT）的结合在评估乳腺癌新辅助化疗（NAC）后的病理反应中的作用
5. Coregistration of serial breast MR studies for augmenting neoadjuvant chemotherapy response evaluation in breast cancer patients. [D] . Chittineni, Ruparani. 2008

机译：增强乳腺癌患者新系列辅助化疗反应评估的系列乳房MR研究的核心。
6. Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide followed by adjuvant capecitabine/docetaxel vs docetaxel in patients with operable breast cancer [O] . Minmin Zhang, Wei Wei, Jianlun Liu, 2016

机译：在可手术乳腺癌患者中新辅助化疗方案卡培他滨/厄比霉素/环磷酰胺与5-氟尿嘧啶/厄比霉素/环磷酰胺再辅以卡培他滨/多西他赛与多西他赛的疗效和毒性比较
7. Erratum to: Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial [O] . Milagros González-Rivera, Miriam Lobo, Sara López-Tarruella, 2017

机译：错误至：参与基于铂族的新辅助化疗试验的三重阴性乳腺癌患者未选择性前瞻性群体中的种系DNA遗传发现的频率

Evaluation of germline whole exome sequencing of early breast cancer patients with triple negative breast cancer (TNBC) included in a prospective study of neoadjuvant chemotherapy (NAC) with epirubicin and cyclophosphamide (EC) and carboplatin-paclitaxel (PC) (BSMO 2014-01)

著录项

引文网络

相似文献

相关主题

期刊订阅